Sign In
Buy BDX
$145.61
+1.18 (+0.82%)
At Close: Jun 03, 2026
BD Joins the Race to Zero: Largest Alliance Dedicated to Achieving Net Zero Emissions by 2050
06:50am, Wednesday, 22'nd Sep 2021
FRANKLIN LAKES, N.J., Sept. 22, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, with support from a number of partners including Glob
BD Partners with Washington State in Back-to-School Testing Effort
06:50am, Tuesday, 21'st Sep 2021
FRANKLIN LAKES, N.J., Sept. 21, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been selected by the state of W
Cybersecurity Gains Prominence in MedTech: 3 Stocks to Focus on
09:55am, Friday, 17'th Sep 2021
Technology-based healthcare stocks like Henry Schein (HSIC), Veeva Systems (VEEV) and BD (BDX) are expected to continue their rally over the next few months.
Becton Dickinson CEO on first Covid smartphone test and how it works
04:03pm, Friday, 10'th Sep 2021
Thomas Polen, Becton Dickenson CEO, joins Closing Bell to talk about his company's smartphone Covid test.
Why Biden's Action Plan Is Bullish For COVID-19 Testing Stocks
11:56am, Friday, 10'th Sep 2021
On Thursday, President Joe Biden revealed his new COVID-19 action plan, which includes $2 billion in government spending on 280 million rapid point of care and at-home COVID-19 tests. On Friday, Bank
Becton, Dickinson And Company: One Of The Best Dividend SWANs You Can Buy Today
02:00am, Friday, 10'th Sep 2021
Becton, Dickinson And Company: One Of The Best Dividend SWANs You Can Buy Today
Notable Becton Dickinson Insider Trades $5.72 Million In Company Stock
02:14pm, Tuesday, 07'th Sep 2021
James Lim, Executive Vice President at Becton, Dickinson (NYSE:BDX), made a large buy and sell of company shares on September 3, according to a new SEC filing. What Happened: A Form 4 filing from the
BD's (BDX) Latest Diagnostic System to Improve Lab Efficiency
12:58pm, Tuesday, 31'st Aug 2021
BD's (BDX) new system is expected to address labs' needs for high-volume processing and increases in efficiency.
BD to Present at Two Upcoming Virtual Healthcare Investor Conferences in September
04:45pm, Thursday, 26'th Aug 2021
FRANKLIN LAKES, N.J., Aug. 26, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will present at the
BD (BDX) Veritor At-Home COVID-19 Test Receives EUA From FDA
01:01pm, Thursday, 26'th Aug 2021
EUA for BD's (BDX) At-Home COVID-19 test is expected to boost home testing to prevent outbreaks and limit the rise in COVID-19 cases from the Delta variant.
Here's Why You Should Retain BD (BDX) Stock in Your Portfolio
12:14pm, Thursday, 26'th Aug 2021
Investors continue to be optimistic about BD (BDX) owing to its slew of product launches and regulatory approvals.
BD Locks FDA Emergency Use Nod For At-Home COVID-19 Antigen Test
09:02am, Thursday, 26'th Aug 2021
The FDA has issued an Emergency Use Authorization (EUA) for Becton Dickinson and Co's (NYSE: BDX) BD Veritor At-Home COVID-19 Test. Also Read: BD's Automated Molecular Diagnostics Platform Wins
BD Receives Emergency Use Authorization for First At-Home COVID-19 Test to Use Smartphone to Interpret, Deliver Results
04:10pm, Wednesday, 25'th Aug 2021
FRANKLIN LAKES, N.J., Aug. 25, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the U.S. Food and Drug Administration
BD's Automated Molecular Diagnostics Platform Wins FDA Approval, Initial Test For HPV
01:46pm, Wednesday, 25'th Aug 2021
Becton Dickinson and Co (NYSE: BDX) has received FDA approval for its automated, sample-to-answer, high-throughput BD Cor system along with the BD Onclarity HPV Assay for extended genotyping of hum
BD Launches Fully Automated High-Throughput Molecular Diagnostic Platform for U.S. Laboratories
06:50am, Wednesday, 25'th Aug 2021
FRANKLIN LAKES, N.J., Aug. 25, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has launched a new, fully auto
